Multicenter evaluation of a pathogenic mycobacterium screening probe.

Area of Science:

• Clinical microbiology
• Molecular diagnostics
• Infectious disease detection

Background:

• Nucleic acid amplification assays have improved Mycobacterium tuberculosis complex (MTBC) diagnosis.
• Non-MTBC mycobacteria cause disease, particularly in immunocompromised individuals.
• Rapid detection of diverse pathogenic mycobacteria is clinically significant.

Purpose of the Study:

• To evaluate a novel screening assay for detecting major pathogenic mycobacterial species.
• To assess the performance of the KY493 screening probe in a multicenter clinical study.
• To compare the screening probe's accuracy against species-specific probes, a genus-specific probe, and culture.

Main Methods:

• Development of a screening assay using pan-genus primers for mycobacterial DNA amplification.
• Utilization of the KY493 probe for detecting all major pathogenic mycobacteria.
• Multicenter European study involving comparison with M. tuberculosis, M. avium, M. intracellulare specific probes, a genus-specific probe, and culture.

Main Results:

• The KY493 screening probe demonstrated sensitivity equivalent to species-specific probes.
• Compared to culture, the screening probe achieved 89% sensitivity and 93.9% specificity.
• The assay showed similar sensitivity to culture when clinical data were considered, with a lower positive predictive value.

Conclusions:

• The KY493 screening probe is a valuable tool for rapid mycobacterial disease diagnosis.
• The assay offers improved sensitivity over smear microscopy.
• This screening approach aids in identifying a broad range of pathogenic mycobacteria in clinical settings.